Health - Sep 25
German Ministry of Education & Research provides almost 1.6 million euros for the 'One Health Platform' at Münster site
German Ministry of Education & Research provides almost 1.6 million euros for the 'One Health Platform' at Münster site
Research management - Sep 22
University of Freiburg among the best ten universities in Germany in the QS World University Rankings Europe 2024
University of Freiburg among the best ten universities in Germany in the QS World University Rankings Europe 2024
Architecture - Sep 22
Greix-Decline in apartment prices mainly affects existing stock, new construction prices relatively stable
Greix-Decline in apartment prices mainly affects existing stock, new construction prices relatively stable
Politics - Sep 21
'On the way between the worlds' - career of a former GDR diplomat before and after the fall of the Wall
'On the way between the worlds' - career of a former GDR diplomat before and after the fall of the Wall
Campus UNI-POTSDAM - Sep 20
President of the University of Potsdam Re-Elected for Another Six Years - Prof. Oliver Günther, Ph.D., Wants to Stay on Course
President of the University of Potsdam Re-Elected for Another Six Years - Prof. Oliver Günther, Ph.D., Wants to Stay on Course
wire - news in brief
« BACK
Health - Pharmacology - 14.09.2023 
Cold plasma makes wounds heal faster
The gold standard for the treatment of chronic wounds is thus obsolete . Once the leg is open, patients often begin a long journey of suffering.
Pharmacology - 13.09.2023 
Co-crystal improves the water-solubility of ASA
This could benefit patients diagnosed with suspected acute myocardial infarction. For decades, researchers have been looking for ways to make the active ingredient acetylsalicylic acid (ASA) - the active ingredient of Aspirin - more water-soluble.
Health - Pharmacology - 28.08.2023 
High mortality in cardiogenic shock despite extracorporeal life support (ECLS)
The use of active mechanical circulatory support is growing rapidly around the world. The hope is that these systems will improve survival after the most severe form of acute heart failure, cardiogenic shock.
Health - Pharmacology - 25.08.2023
Health - Pharmacology - 08.08.2023 
How do people really feel about electronic health records?
Many people with statutory health insurance don't understand the digital infrastructure behind electronic health records. One issue in particular raises concerns. In Germany, patients with statutory health insurance have had the option of using an electronic health record since January 2021. However, not many people have been taking advantage of it so far.
Health - Pharmacology - 31.07.2023
Pharmacology - Health - 04.07.2023
Pharmacology - Health - 04.07.2023 
Milestone in the treatment of anaemia in myelodysplastic neoplasms (MDS)
In patients suffering from myelodysplastic neoplasms (MDS), a group of often mildly progressing bone marrow disorders, the body does not produce enough functional blood cells.
Pharmacology - 28.06.2023
Health - Pharmacology - 20.06.2023
Pharmacology - 06.06.2023
Pharmacology - Health - 28.04.2023 
Clinical trial to test new combination therapy against blood cancer
The MHH is looking for subjects with an IDH1 gene mutation for a multicenter study on the combination therapy of two drugs previously used individually against acute myeloid leukemia (AML) 28.
Health - Pharmacology - 24.04.2023 
Improving the lives of MS patients
Reading time 9 min. Research at the new Center for Multiple Sclerosis and Neurosciences The TUM scientists and physicians and the patients at the Center for Multiple Sclerosis and Neurosciences, to open in 2025, will share a common objective: Making life with multiple sclerosis better. Many open questions will be answered - for example why the illness has such a variety of forms, particularly in its initial stages, and how to stop nerve cell death in the later stages.
Health - Pharmacology - 03.04.2023
Health - Pharmacology - 22.03.2023 
’Not many natural scientists can offer the combination of basic research and clinically oriented research.’
The -InFlame- Medical Scientist Programme supports postdocs from natural science disciplines to conduct medical research on inflammatory processes / Interview with the programme spokesperson Petra De
Health - Pharmacology - 28.02.2023 
Drug from cancer chemotherapy helps fight deadly fungal infections
Infections with the fungus Aspergillus fumigatus are difficult to fight - especially because the fungus forms a biofilm and can thus protect itself from antifungal drugs and the immune defence system.
Health - Pharmacology - 21.02.2023
Health - Pharmacology - 17.02.2023 
Interactive risk communication can help overcome vaccine hesitancy
Study on the impact of different risk communication formats on the vaccine intentions of 1255 unvaccinated, vaccine-hesitant adults in Germany Interactive risk communication formats can be more effective than conventional text-based formats in overcoming vaccine hesitancy and building public trust.
Pharmacology - Health - 16.02.2023 
Iron deficiency in heart failure: tablet as an alternative to infusion?
MHH cardiology starts the multicentre ORION HF study. She wants to find out whether a preparation in tablet form can correct iron deficiency and alleviate the typical symptoms of heart failure.
Health - Pharmacology - 15.02.2023 
Innovative care project for people with schizophrenia
The patients themselves choose between several treatment options. The aim of the project is to increase the quality of life and improve the success of treatment.
Pharmacology - Health - 30.01.2023
Innovation - Pharmacology - 30.01.2023
Pharmacology - Health - 21.12.2022 
A pioneer of innovative training
The -PharMSchool- started up ten years ago and is a lighthouse project for interdisciplinary, networked teaching Can therapeutic plasters help to combat depression?
Health - Pharmacology - 12.12.2022 
Progress in the fight against bile duct cancer and gallbladder cancer
International expert committee led by Professor Arndt Vogel updates ESMO treatment guidelines for biliary tract cancer Biliary tract cancers (BTC) are cancers of the bile ducts and gallbladder.
Health - Pharmacology - 08.12.2022 
Using immune cells to develop new active substances and improve the efficacy and safety of drugs
MHH researcher Nico Lachmann receives 2.5 million euros for Fraunhofer-Attract group Immune cells and immune cell preparations are playing an increasingly important role in modern medicine&per
Health - Pharmacology - 21.11.2022 
Together against Antibiotic Resistance
Antibiotics are major weapons in the fight against bacterial infections. However, antibiotics are increasingly losing efficacy due to the emergence of antibiotic resistance.
Health - Pharmacology - 27.06.2022 
MHH Sarcoma Center successfully DKG-certified
Treatment of rare tumors: In addition to soft tissue tumors, the MHH is the only center in Lower Saxony to be certified for bone sarcomas.
Health - Pharmacology - 22.06.2022 
The path to personalised hepatitis D treatment
EU supports multicentre project with a total of 6.75 million euros Hepatitis D is by far the most severe form of chronic viral hepatitis, often leading to liver failure, liver cancer and death.
Chemistry - Pharmacology - 14.06.2022
Health - Pharmacology - 13.06.2022
Pharmacology - Health - 09.06.2022 
Concerns about new mutations as vaccine willingness slightly decreases
Two-thirds of the German population are concerned about new corona mutations; one-fifth of the population is very worried.
Health - Pharmacology - 30.05.2022
Health - Pharmacology - 29.04.2022 
COVID-19: How vaccination and previous infections also help fight against Omicron
Immune cells against previous Sars-CoV-2 variants also recognize Omicron well and can thus protect against severe disease / Vaccination can improve immune response even after infection / Study by Frei
Pharmacology - Health - 28.03.2022
Health - Pharmacology - 24.03.2022 
Equal is better? How people think Covid-19 vaccines should be shared worldwide
Health and logistics researchers at Göttingen University analyze attitudes in Germany and America The Covid-19 pandemic has fundamentally changed the world.
Pharmacology - Health - 18.03.2022
Health - Pharmacology - 15.03.2022 
Help to develop the medicine of tomorrow!
Medical Informatics Initiative: MHH asks patients for support As of today, all inpatients at Hannover Medical School (MHH) can support medical research with their treatment data.
Health - Pharmacology - 14.03.2022 
With water jet and steam against prostate disorders
MHH Urology completes the treatment spectrum for benign prostate enlargement with two gentle procedures A frequent urge to urinate, going to the toilet at night, irregular urine stream - many men are familiar with these complaints.
Health - Pharmacology - 09.03.2022
Pharmacology - Health - 22.02.2022
Health - Pharmacology - 18.02.2022
Health - Pharmacology - 18.02.2022 
Infectious agent offers protection against liver cancer
Joint study by MHH and HZI: vaccine proves safe and effective against liver fibrosis and liver cancer Liver cancer is the third most common cause of cancer-related deaths worldwide. So far, the treatment options for two types of liver cancer, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), have been inadequate, while the number of new cases has been rising.
Pharmacology - Health - 01.02.2022
Pharmacology - Chemistry - 28.01.2022
Health - Pharmacology - 19.01.2022
Pharmacology - Health - 13.01.2022
Health - Pharmacology - 13.01.2022 
A spray to protect against lung damage from Covid-19
Rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases.
Health - Pharmacology - 03.01.2022
Health - Pharmacology - 14.12.2021
Health - Pharmacology - 09.12.2021 
The long-term effects of sepsis: years of treatment and care needs
Three in four sepsis survivors experience new-onset memory problems, psychological impairments or physical diagnoses. This also applies to more than half of sepsis survivors under the age of 40 at the time of their discharge from hospital. These are just two of the findings of a retrospective analysis of anonymized health claims data conducted by a team of researchers from Jena University Hospital, Charité - Universitätsmedizin Berlin and the Research Institute of the Local Health Care Funds (AOK).
Pharmacology
Results 1 - 50 of 104.
The gold standard for the treatment of chronic wounds is thus obsolete . Once the leg is open, patients often begin a long journey of suffering.
This could benefit patients diagnosed with suspected acute myocardial infarction. For decades, researchers have been looking for ways to make the active ingredient acetylsalicylic acid (ASA) - the active ingredient of Aspirin - more water-soluble.
The use of active mechanical circulatory support is growing rapidly around the world. The hope is that these systems will improve survival after the most severe form of acute heart failure, cardiogenic shock.
Many people with statutory health insurance don't understand the digital infrastructure behind electronic health records. One issue in particular raises concerns. In Germany, patients with statutory health insurance have had the option of using an electronic health record since January 2021. However, not many people have been taking advantage of it so far.
Interdisciplinary teamwork reduces complications in bone fractures
University physicians planning to develop a digital experts- forum with the EXPERT project An injury in a car accident, a twisted ankle while out jogging, a fall at home: bone fractures can occur very quickly.
University physicians planning to develop a digital experts- forum with the EXPERT project An injury in a car accident, a twisted ankle while out jogging, a fall at home: bone fractures can occur very quickly.
Milestone in the treatment of anaemia in chronic lymphocytic leukaemia
International Clinical Trial Shows Alternative to Standard Treatment of Myelodysplastic Neoplasms In people with myelodysplastic neoplasms (MDS), a usually benign form of chronic lymphocytic leukaemia, the body produces too few functional blood cells.
International Clinical Trial Shows Alternative to Standard Treatment of Myelodysplastic Neoplasms In people with myelodysplastic neoplasms (MDS), a usually benign form of chronic lymphocytic leukaemia, the body produces too few functional blood cells.
In patients suffering from myelodysplastic neoplasms (MDS), a group of often mildly progressing bone marrow disorders, the body does not produce enough functional blood cells.
The MHH is looking for subjects with an IDH1 gene mutation for a multicenter study on the combination therapy of two drugs previously used individually against acute myeloid leukemia (AML) 28.
Reading time 9 min. Research at the new Center for Multiple Sclerosis and Neurosciences The TUM scientists and physicians and the patients at the Center for Multiple Sclerosis and Neurosciences, to open in 2025, will share a common objective: Making life with multiple sclerosis better. Many open questions will be answered - for example why the illness has such a variety of forms, particularly in its initial stages, and how to stop nerve cell death in the later stages.
Nasal Vaccine to Prevent Covid-19 Passes First Tests
Scientists in Berlin have developed a live attenuated vaccine for the nose and recently published a study in "Nature Microbiology" Joint press release by Freie Universität Berlin, Max Delbrück Center, and Charité - Universitätsmedizin Berlin Coronaviruses spread primarily through the air.
Scientists in Berlin have developed a live attenuated vaccine for the nose and recently published a study in "Nature Microbiology" Joint press release by Freie Universität Berlin, Max Delbrück Center, and Charité - Universitätsmedizin Berlin Coronaviruses spread primarily through the air.
The -InFlame- Medical Scientist Programme supports postdocs from natural science disciplines to conduct medical research on inflammatory processes / Interview with the programme spokesperson Petra De
Infections with the fungus Aspergillus fumigatus are difficult to fight - especially because the fungus forms a biofilm and can thus protect itself from antifungal drugs and the immune defence system.
Study on the impact of different risk communication formats on the vaccine intentions of 1255 unvaccinated, vaccine-hesitant adults in Germany Interactive risk communication formats can be more effective than conventional text-based formats in overcoming vaccine hesitancy and building public trust.
MHH cardiology starts the multicentre ORION HF study. She wants to find out whether a preparation in tablet form can correct iron deficiency and alleviate the typical symptoms of heart failure.
The patients themselves choose between several treatment options. The aim of the project is to increase the quality of life and improve the success of treatment.
The -PharMSchool- started up ten years ago and is a lighthouse project for interdisciplinary, networked teaching Can therapeutic plasters help to combat depression?
International expert committee led by Professor Arndt Vogel updates ESMO treatment guidelines for biliary tract cancer Biliary tract cancers (BTC) are cancers of the bile ducts and gallbladder.
MHH researcher Nico Lachmann receives 2.5 million euros for Fraunhofer-Attract group Immune cells and immune cell preparations are playing an increasingly important role in modern medicine&per
Antibiotics are major weapons in the fight against bacterial infections. However, antibiotics are increasingly losing efficacy due to the emergence of antibiotic resistance.
Treatment of rare tumors: In addition to soft tissue tumors, the MHH is the only center in Lower Saxony to be certified for bone sarcomas.
EU supports multicentre project with a total of 6.75 million euros Hepatitis D is by far the most severe form of chronic viral hepatitis, often leading to liver failure, liver cancer and death.
Mulliken Center of the University of Bonn and Merck cooperate in machine learning project
The Mulliken Center for Theoretical Chemistry at the University of Bonn is collaborating with Merck.
The Mulliken Center for Theoretical Chemistry at the University of Bonn is collaborating with Merck.
Two-thirds of the German population are concerned about new corona mutations; one-fifth of the population is very worried.
Immune cells against previous Sars-CoV-2 variants also recognize Omicron well and can thus protect against severe disease / Vaccination can improve immune response even after infection / Study by Frei
Health and logistics researchers at Göttingen University analyze attitudes in Germany and America The Covid-19 pandemic has fundamentally changed the world.
Medical Informatics Initiative: MHH asks patients for support As of today, all inpatients at Hannover Medical School (MHH) can support medical research with their treatment data.
MHH Urology completes the treatment spectrum for benign prostate enlargement with two gentle procedures A frequent urge to urinate, going to the toilet at night, irregular urine stream - many men are familiar with these complaints.
Majority of Freiburg school pupils approve of compulsory mask wearing and vaccination in the pandemic
Survey of 636 school pupils in the Freiburg area on their perception of the corona pandemic To find out how Freiburg school pupils are doing in the enduring corona pandemic, Dr. Sebastian Jäck
Survey of 636 school pupils in the Freiburg area on their perception of the corona pandemic To find out how Freiburg school pupils are doing in the enduring corona pandemic, Dr. Sebastian Jäck
Joint study by MHH and HZI: vaccine proves safe and effective against liver fibrosis and liver cancer Liver cancer is the third most common cause of cancer-related deaths worldwide. So far, the treatment options for two types of liver cancer, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), have been inadequate, while the number of new cases has been rising.
New insights into predicting the efficacy of active ingredients in drug development
Drugs consist of molecules developed in the drug laboratory that bind to their target, usually a protein, and thus exert their effect. The actual duration of binding of a drug molecule to its target protein varies depending on the drug. The lifetime of the drug-target complex can play a critical role in the efficacy of a drug, as a long residence time at the target can be crucial for the drug's action in some cases.
Drugs consist of molecules developed in the drug laboratory that bind to their target, usually a protein, and thus exert their effect. The actual duration of binding of a drug molecule to its target protein varies depending on the drug. The lifetime of the drug-target complex can play a critical role in the efficacy of a drug, as a long residence time at the target can be crucial for the drug's action in some cases.
Fungal infections in Africa: no adequate treatment despite millions of affected patients
Together with an international team of experts, Professor Dr Oliver Cornely, head of the European Excellence Center for Invasive Fungal Infections at University Hospital Cologne, has conducted a study to investigate the current situation of clinical mycology - the treatment of fungal diseases - on the African continent, revealing significant deficits.
Together with an international team of experts, Professor Dr Oliver Cornely, head of the European Excellence Center for Invasive Fungal Infections at University Hospital Cologne, has conducted a study to investigate the current situation of clinical mycology - the treatment of fungal diseases - on the African continent, revealing significant deficits.
Rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases.
A medication against SARS-CoV-2
Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide partnership. But mediacations against Covid-19 have as yet seen only partial success. With the support of the Bavarian Research Foundation, a Munich research team has developed a protein which has reliably prevented infection by the virus and its variants in cell tests.
Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide partnership. But mediacations against Covid-19 have as yet seen only partial success. With the support of the Bavarian Research Foundation, a Munich research team has developed a protein which has reliably prevented infection by the virus and its variants in cell tests.
Three in four sepsis survivors experience new-onset memory problems, psychological impairments or physical diagnoses. This also applies to more than half of sepsis survivors under the age of 40 at the time of their discharge from hospital. These are just two of the findings of a retrospective analysis of anonymized health claims data conducted by a team of researchers from Jena University Hospital, Charité - Universitätsmedizin Berlin and the Research Institute of the Local Health Care Funds (AOK).
Health - Sep 25
German Ministry of Education & Research provides almost 1.6 million euros for the 'One Health Platform' at Münster site
German Ministry of Education & Research provides almost 1.6 million euros for the 'One Health Platform' at Münster site
Research management - Sep 22
University of Freiburg among the best ten universities in Germany in the QS World University Rankings Europe 2024
University of Freiburg among the best ten universities in Germany in the QS World University Rankings Europe 2024
Architecture - Sep 22
Greix-Decline in apartment prices mainly affects existing stock, new construction prices relatively stable
Greix-Decline in apartment prices mainly affects existing stock, new construction prices relatively stable
Politics - Sep 21
'On the way between the worlds' - career of a former GDR diplomat before and after the fall of the Wall
'On the way between the worlds' - career of a former GDR diplomat before and after the fall of the Wall
Campus UNI-POTSDAM - Sep 20
President of the University of Potsdam Re-Elected for Another Six Years - Prof. Oliver Günther, Ph.D., Wants to Stay on Course
President of the University of Potsdam Re-Elected for Another Six Years - Prof. Oliver Günther, Ph.D., Wants to Stay on Course